BACKGROUND: The purpose of our study was to determine the rate of carpal tunnel decompression (CTD) following local corticosteroid injection for carpal tunnel syndrome (CTS), as well as identifying predictors of requiring further intervention and eventual decompression. METHODS: All patients diagnosed with CTS in our unit over a 6-year period were prospectively assessed. Patients were diagnosed using a combination of clinical presentation and nerve conduction studies. Patients were managed with open carpal tunnel decompression or corticosteroid injection. There were 1,564 consecutive patients diagnosed with CTS over the study period, of whom 824 (53%) underwent a corticosteroid injection as their primary treatment. We performed a survivorship analysis of these patients and used Kaplan-Meier survivorship methodology to determine the 5-year rate of re-intervention. Risk factors for re-intervention were also determined. RESULTS: The overall 5-year Kaplan-Meier rate of secondary CTD was 15% at 1 year and 33% at 5 years. The need for secondary CTD was independently associated with female gender, diabetes mellitus and positive nerve conduction studies at diagnosis. CONCLUSIONS: Steroid injection is an appropriate treatment in carefully selected patients. Those who are female, diabetic and have neurophysiological confirmation of diagnosis have the highest risk of relapse. These results may be used to guide initial treatment and counsel patients about the risk relapse.
BACKGROUND: The purpose of our study was to determine the rate of carpal tunnel decompression (CTD) following local corticosteroid injection for carpal tunnel syndrome (CTS), as well as identifying predictors of requiring further intervention and eventual decompression. METHODS: All patients diagnosed with CTS in our unit over a 6-year period were prospectively assessed. Patients were diagnosed using a combination of clinical presentation and nerve conduction studies. Patients were managed with open carpal tunnel decompression or corticosteroid injection. There were 1,564 consecutive patients diagnosed with CTS over the study period, of whom 824 (53%) underwent a corticosteroid injection as their primary treatment. We performed a survivorship analysis of these patients and used Kaplan-Meier survivorship methodology to determine the 5-year rate of re-intervention. Risk factors for re-intervention were also determined. RESULTS: The overall 5-year Kaplan-Meier rate of secondary CTD was 15% at 1 year and 33% at 5 years. The need for secondary CTD was independently associated with female gender, diabetes mellitus and positive nerve conduction studies at diagnosis. CONCLUSIONS:Steroid injection is an appropriate treatment in carefully selected patients. Those who are female, diabetic and have neurophysiological confirmation of diagnosis have the highest risk of relapse. These results may be used to guide initial treatment and counsel patients about the risk relapse.
Authors: Hyun Sik Gong; Goo Hyun Baek; Joo Han Oh; Young Ho Lee; Suk Ha Jeon; Moon Sang Chung Journal: J Bone Joint Surg Am Date: 2009-09 Impact factor: 5.284
Authors: Mohammad Hosseini-Farid; Verena J M M Schrier; Julia Starlinger; Peter C Amadio Journal: J Ultrasound Med Date: 2020-10-19 Impact factor: 2.153
Authors: Stefanie Evers; Andrew J Bryan; Thomas L Sanders; Tina Gunderson; Russell Gelfman; Peter C Amadio Journal: J Hand Surg Am Date: 2018-04-14 Impact factor: 2.230
Authors: Stefanie Evers; Andrew J Bryan; Thomas L Sanders; Tina Gunderson; Russell Gelfman; Peter C Amadio Journal: Plast Reconstr Surg Date: 2017-08 Impact factor: 4.730
Authors: Mohammad Ghasemi-Rad; Emad Nosair; Andrea Vegh; Afshin Mohammadi; Adam Akkad; Emal Lesha; Mohammad Hossein Mohammadi; Doaa Sayed; Ali Davarian; Tooraj Maleki-Miyandoab; Anwarul Hasan Journal: World J Radiol Date: 2014-06-28
Authors: Mohammad Hosseini-Farid; Verena J M M Schrier; Julia Starlinger; Chunfeng Zhao; Peter C Amadio Journal: Clin Biomech (Bristol, Avon) Date: 2021-07-24 Impact factor: 2.034
Authors: Lasitha B Samarakoon; Malith H Guruge; Madusha Jayasekara; Ajith P Malalasekera; Dimonge J Anthony; Rohan W Jayasekara Journal: Patient Saf Surg Date: 2014-02-17